These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 1240176)

  • 1. [Morphological changes of oral Fusobacterium caused by antibiotics].
    Kitano S; Tamaki K; Yamaoka Y; Miyakawa M; Katayama A
    Nihon Saikingaku Zasshi; 1975 Jan; 30(1):106. PubMed ID: 1240176
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro susceptibility of oral spirochetes to metronidazole.
    Le Clair RA; Keetin LM
    J Dent Res; 1970; 49(6):Suppl:1513-6. PubMed ID: 4922198
    [No Abstract]   [Full Text] [Related]  

  • 3. [Electron microscopic study of the combined action of ampicillin and cephalexin on E. coli].
    Chavdarova V; Cherepanova N; Kharizanova T; Avramova R
    Antibiotiki; 1977 Jun; 22(6):536-9. PubMed ID: 329750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fundamental studies on the dynamic movement of oral microbes. 9. Inhibitory action of sodium fluoride on bacterial growth and glycolysis].
    Takei M; Suzuki T; Furukawa S; Iwasaki S
    Aichi Gakuin Daigaku Shigakkai Shi; 1969 Mar; 6(3):341-4. PubMed ID: 5266661
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral Fusobacterium, Leptotrichia and Bacterionema: II. Pathogenicity: a review of the literature.
    Krywolap GN; Page LR
    J Baltimore Coll Dent Surg; 1977 Jul; 32(1):26-32. PubMed ID: 370083
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral Fusobacterium, Leptotrichia and Bacterionema: I. Hisorical survey and taxonomic considerations.
    Page LR; Krywolap GN
    J Baltimore Coll Dent Surg; 1977 Jul; 32(1):12-24. PubMed ID: 370082
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of the sensitivity to antibiotics of Bacteroides and Fusobacterium using the ATB ANA system].
    Monteil H; Rasoamananjara D; Vetter MT
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):648-52. PubMed ID: 3534761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial action of green tea extract, flavono flavor and copper chlorophyll against oral bacteria.
    Saeki Y; Ito Y; Shibata M; Sato Y; Takazoe I; Okuda K
    Bull Tokyo Dent Coll; 1993 Feb; 34(1):33-7. PubMed ID: 8375014
    [No Abstract]   [Full Text] [Related]  

  • 9. Antimicrobial constituents from goldenseal (the Rhizomes of Hydrastis canadensis) against selected oral pathogens.
    Hwang BY; Roberts SK; Chadwick LR; Wu CD; Kinghorn AD
    Planta Med; 2003 Jul; 69(7):623-7. PubMed ID: 12898417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphological characteristics of oral fusobacteria as revealed by the electron microscope.
    HAMPP EG; SCOTT DB; WYCKOFF RW
    J Bacteriol; 1960 May; 79(5):716-28. PubMed ID: 14399384
    [No Abstract]   [Full Text] [Related]  

  • 11. Isolation of Leptotrichia buccalis and Fusobacterium species from oral material.
    BAIRD-PARKER AC
    Nature; 1957 Nov; 180(4594):1056-7. PubMed ID: 13483608
    [No Abstract]   [Full Text] [Related]  

  • 12. [A study on hemagglutinating activity of oral Fusobacterium (author's transl)].
    Sawamura N
    Shikwa Gakuho; 1982 Feb; 82(2):271-81. PubMed ID: 6955952
    [No Abstract]   [Full Text] [Related]  

  • 13. [Fundmanetal studies of the dynamic movement of oral microbes. 8. Relationship of neisseria and fusobacterium].
    Takei M; Fukatsu T; Tomatsu Y
    Aichi Gakuin Daigaku Shigakkai Shi; 1968 Sep; 6(2):210-5. PubMed ID: 5251522
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of amoxicillin, cephalexin, and tetracycline-HCl on intestinal L-leucine transport in the rat in vivo.
    Barcina Y; Ilundain A; Larralde J
    Drug Nutr Interact; 1988; 5(4):283-8. PubMed ID: 3240711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic and genotypic analyses of clinical Fusobacterium nucleatum and Fusobacterium periodonticum isolates from the human gut.
    Strauss J; White A; Ambrose C; McDonald J; Allen-Vercoe E
    Anaerobe; 2008 Dec; 14(6):301-9. PubMed ID: 19114111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Activity of cefotetan against anaerobic bacteria].
    Sedallian A
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):643-4. PubMed ID: 2877431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial susceptibility of 800 anaerobic isolates from patients with dentoalveolar infection to 13 oral antibiotics.
    Kuriyama T; Williams DW; Yanagisawa M; Iwahara K; Shimizu C; Nakagawa K; Yamamoto E; Karasawa T
    Oral Microbiol Immunol; 2007 Aug; 22(4):285-8. PubMed ID: 17600542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Means of purification of cephalexin with a view to therapeutic use].
    Stan C; Dumitrache M; Diaconu DE
    Rev Med Chir Soc Med Nat Iasi; 2004; 108(3):718-20. PubMed ID: 15833005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The sensitivity of Fusiformis nodosus to antibiotics].
    Grishaev NV
    Veterinariia; 1971; 7():112-3. PubMed ID: 5170257
    [No Abstract]   [Full Text] [Related]  

  • 20. [Oral vibrions method of isolation and demonstration of their relation to Sherophorus fusiformis].
    Bérenholc S; Carlier JP
    Actual Odontostomatol (Paris); 1976 Dec; (116):713-24. PubMed ID: 1020709
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.